Back
Matinas BioPharma Holdings Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
38
MTNB
Matinas BioPharma Holdings
Last Price:
$0.65
Seasonality Move:
-12.07%
Sell
50
RYTM
Rhythm Pharmaceuticals
Last Price:
$56.77
Seasonality Move:
54.9%
Sell
38
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy, Sell or Hold?
-
The current Matinas BioPharma Holdings [MTNB] share price is $0.63. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
MTNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Rhythm Pharmaceuticals (RYTM)
is a Sell
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $58.97. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MTNB Stock Price Chart
What is Matinas BioPharma Holdings's stock price today?
-
The Matinas BioPharma Holdings share price today is $0.63The current trend is moderately bullish and MTNB is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $58.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
MTNB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 51.9 | Buy |
| Chaikin Money Flow: | -73472 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.04 | Buy |
| Relative Strength Index (14 RSI): | 46.88 | Sell |
| Chaikin Money Flow: | 27337 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
MTNB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.66 | Sell |
| 20-day SMA: | 0.62 | Buy |
| 50-day SMA: | 0.58 | Buy |
| 200-day SMA: | 2.04 | Sell |
| 8-day EMA: | 0.66 | Sell |
| 20-day EMA: | 0.63 | Buy |
| 50-day EMA: | 0.62 | Buy |
| 200-day EMA: | 2.55 | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.08 | Sell |
| 20-day SMA: | 62.15 | Sell |
| 50-day SMA: | 56.78 | Buy |
| 200-day SMA: | 54.27 | Buy |
| 8-day EMA: | 61.17 | Sell |
| 20-day EMA: | 61 | Sell |
| 50-day EMA: | 58.76 | Buy |
| 200-day EMA: | 53.68 | Buy |
Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.56 per share, and a decrease next year of $2.50 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.17 per share, an increase this year of $1.44 per share, and an increase next year of $1.20 per share.
Matinas BioPharma Holdings Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||